Back
Direxion Daily S&P Biotech Bull 3X Shares Vs. Nektar Therapeutics Industry Stock Comparison
Sell
44
LABU
Direxion Daily S&P Biotech Bull 3X Shares
Last Price:
$155.99
Seasonality Move:
-4.1%
Sell
42
NKTR
Nektar Therapeutics
Last Price:
$45.42
Seasonality Move:
11.58%
Sell
44
Direxion Daily S&P Biotech Bull 3X Shares (LABU)
is a Sell
Is Direxion Daily S&P Biotech Bull 3X Shares a Buy, Sell or Hold?
-
The current Direxion Daily S&P Biotech Bull 3X Shares [LABU] share price is $160.20. The Score for LABU is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
LABU is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LABU Stock Price Chart
What is Direxion Daily S&P Biotech Bull 3X Shares's stock price today?
-
The Direxion Daily S&P Biotech Bull 3X Shares share price today is $160.20The current trend is moderately bullish and LABU is experiencing slight buying pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $49.16Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.
LABU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.16 | Buy |
| Relative Strength Index (14 RSI): | 58.58 | Buy |
| Chaikin Money Flow: | 52920 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (138.04 - 165.26) | Buy |
| Bollinger Bands (100): | (70.77 - 138.81) | Buy |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.43 | Sell |
| Relative Strength Index (14 RSI): | 38.92 | Sell |
| Chaikin Money Flow: | 341847 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.73 - 61.13) | Sell |
| Bollinger Bands (100): | (33.63 - 62.73) | Buy |
LABU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 163.22 | Sell |
| 20-day SMA: | 156.3 | Buy |
| 50-day SMA: | 134.56 | Buy |
| 200-day SMA: | 82.15 | Buy |
| 8-day EMA: | 161.84 | Sell |
| 20-day EMA: | 155.01 | Buy |
| 50-day EMA: | 134.84 | Buy |
| 200-day EMA: | 71.82 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.87 | Sell |
| 20-day SMA: | 57.43 | Sell |
| 50-day SMA: | 58.05 | Sell |
| 200-day SMA: | 31.04 | Buy |
| 8-day EMA: | 54.11 | Sell |
| 20-day EMA: | 56.28 | Sell |
| 50-day EMA: | 55.42 | Sell |
| 200-day EMA: | 38.13 | Buy |
Direxion Daily S&P Biotech Bull 3X Shares Earnings Growth & LABU Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.
Direxion Daily S&P Biotech Bull 3X Shares Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||